Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations.
<h4>Importance</h4>Herpes zoster infection is common in immunocompromised individuals. Recently, the Advisory Committee on Immunization Practices recommended immunizing with the recombinant zoster vaccine (RZV).<h4>Objective</h4>To evaluate the efficacy, immunogenicity and sa...
Saved in:
| Main Authors: | Fawziah Marra, Michael Yip, Jacquelyn J Cragg, Nirma Khatri Vadlamudi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0313889 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis
by: Fawziah Marra, et al.
Published: (2025-12-01) -
Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada
by: Sydney George, et al.
Published: (2025-04-01) -
Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix<sup>®</sup>) in VZV Seronegative Immunocompromised Adults
by: Andrea Wessely, et al.
Published: (2025-07-01) -
Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies
by: Agnes Mwakingwe-Omari, et al.
Published: (2023-12-01) -
Necrotizing Fasciitis Following Herpes Zoster Ophthalmicus in an Immunocompromised Patient
by: Grazia Maria Cozzupoli, et al.
Published: (2019-01-01)